FLOMAX Drug Patent Profile
✉ Email this page to a colleague
When do Flomax patents expire, and when can generic versions of Flomax launch?
Flomax is a drug marketed by Sanofi and is included in one NDA.
The generic ingredient in FLOMAX is tamsulosin hydrochloride. There are thirty-three drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flomax
A generic version of FLOMAX was approved as tamsulosin hydrochloride by IMPAX LABS on March 2nd, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLOMAX?
- What are the global sales for FLOMAX?
- What is Average Wholesale Price for FLOMAX?
Summary for FLOMAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 109 |
Clinical Trials: | 46 |
Patent Applications: | 1,795 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FLOMAX |
Drug Sales Revenues: | Drug sales revenues for FLOMAX |
What excipients (inactive ingredients) are in FLOMAX? | FLOMAX excipients list |
DailyMed Link: | FLOMAX at DailyMed |
![FLOMAX drug patent expirations Drug patent expirations by year for FLOMAX](/p/graph/s/t/FLOMAX-patent-expirations.png)
![Drug Prices for FLOMAX](/p/graph/drug-price/FLOMAX.png)
![Drug Sales Revenue Trends for FLOMAX](/p/graph/drug-sales-revenues/FLOMAX.png)
Recent Clinical Trials for FLOMAX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hackensack Meridian Health | N/A |
St. Joseph's Healthcare Hamilton | Phase 4 |
NeoTract, Inc. | Phase 4 |
Pharmacology for FLOMAX
Drug Class | alpha-Adrenergic Blocker |
Mechanism of Action | Adrenergic alpha-Antagonists |
Paragraph IV (Patent) Challenges for FLOMAX
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
FLOMAX | Capsules | tamsulosin hydrochloride | 0.4 mg | 020579 | 1 | 2004-12-20 |
US Patents and Regulatory Information for FLOMAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | FLOMAX | tamsulosin hydrochloride | CAPSULE;ORAL | 020579-001 | Apr 15, 1997 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FLOMAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi | FLOMAX | tamsulosin hydrochloride | CAPSULE;ORAL | 020579-001 | Apr 15, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi | FLOMAX | tamsulosin hydrochloride | CAPSULE;ORAL | 020579-001 | Apr 15, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi | FLOMAX | tamsulosin hydrochloride | CAPSULE;ORAL | 020579-001 | Apr 15, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi | FLOMAX | tamsulosin hydrochloride | CAPSULE;ORAL | 020579-001 | Apr 15, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FLOMAX
See the table below for patents covering FLOMAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | 9203592 | DERIVADOS DE SULFAMOIL-FENETILAMINA SUBSTITUIDA. | ⤷ Sign Up |
U.S.S.R. | 1082320 | PROCESS FOR PREPARING SULFAMOYL-SUBSTITUTED DERIVATIVES OF PHENYL-ETHYL AMINE AND THEIR ACID ADDITION SALTS | ⤷ Sign Up |
Japan | S629 | SUSTAINED RELEASE COMPOUND UNIT PHARMACEUTICAL | ⤷ Sign Up |
Ireland | 50862 | SULFAMOYL-SUBSTITUTED PHENETHYLAMINE DERIVATIVES,THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FLOMAX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0034432 | 96C0048 | Belgium | ⤷ Sign Up | PRODUCT NAME: SAQUINAVIR; REGISTRATION NO/DATE: EU/1/96/026/001 19961004 |
0034432 | SPC/GB96/017: EXPIRE | United Kingdom | ⤷ Sign Up | SPC/GB96/017: EXPIRES: 20060201 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |